Under-performance of small bowel biopsy a major reason behind underdiagnosis of celiac disease
Under-performance of small bowel biopsy during endoscopy may be a major reason that celiac disease remains underdiagnosed in the United States, according to a new study published online recently in Gastrointestinal Endoscopy. Investigators at the Celiac Disease Center at Columbia University Medical Center (CUMC) found that the rate of small bowel biopsy is low in this country.
center
columbia
cumc
endoscopy
medical
states
under-performance
united
university
Celiac Disease Underdiagnosis In US May Be Due To Too Few Biopsies
Under-performance of small bowel biopsy during endoscopy may be a major reason that celiac disease remains underdiagnosed in the United States, according to a new study published online recently in Gastrointestinal Endoscopy. Investigators at the Celiac Disease Center at Columbia University Medical Center (CUMC) found that the rate of small bowel biopsy is low in this country...
center
columbia
cumc
endoscopy
medical
states
under-performance
underdiagnosis
united
university
New Genetic Testing Reveals More Prenatal Abnormalities
A new genetic test has resulted in remarkably more applicable information than the current routine of prenatal testing, suggests a new study published in The New England Journal of Medicine. The test uses microarray analysis to more effectively examine a fetus's DNA than is currently possible with the karyotyping method, a visual examination of the fetus's chromosomes. The blinded trial, led by researchers from Columbia University Medical Center, consisted of 4,400 patients at 29 centers throughout the United States. It took them four years to collect all the data...
abnormalities
center
columbia
dna
england
examination
information
medical
medicine
states
united
university
Potential Approach To Treating Atherosclerosis And Other Chronic Inflammatory Diseases
A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women's Hospital (BWH), Mount Sinai School of Medicine, and Massachusetts Institute of Technology, has developed biodegradable nanoparticles that are capable of delivering inflammation-resolving drugs to sites of tissue injury. The nanoparticles, which were successfully tested in mice, have potential for the treatment of a wide array of diseases characterized by excessive inflammation, such as atherosclerosis...
brigham
bwh
center
columbia
cumc
hospital
inflammation
institute
massachusetts
medical
medicine
mount
school
scientists
sinai
technology
treatment
university
New biodegradable nanoparticles deliver inflammation-resolving drugs to sites of tissue injury
A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women's Hospital (BWH), Mount Sinai School of Medicine, and Massachusetts Institute of Technology, has developed biodegradable nanoparticles that are capable of delivering inflammation-resolving drugs to sites of tissue injury.
brigham
bwh
center
columbia
cumc
hospital
institute
massachusetts
medical
medicine
mount
school
scientists
sinai
technology
university
Philip and Cheryl Milstein provide $20M to support advancement of medicine at CUMC
Continuing their family's multigenerational connection to Columbia and support of its leadership in medicine, Philip (CC '71) and Cheryl Milstein (Barnard '82) have made a $20 million commitment to Columbia University Medical Center.
advancement
barnard
center
cheryl
columbia
commitment
connection
cumc
leadership
medical
million
milstein
philip
university